Eleanor J. Cheadle

Manchester, ENG M204BX, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

The Tumour Immune Microenvironment as a Predictor of the Response to Neoadjuvant Therapy in Rectal Cancer.

The Tumour Immune Microenvironment as a Predictor of the Response to Neoadjuvant Therapy in Rectal Cancer.

Journal: Cancers

Published: March 16, 2026

Final results of UK NCRI phase II trial of pembrolizumab and radiotherapy in cutaneous T cell lymphoma.

Final results of UK NCRI phase II trial of pembrolizumab and radiotherapy in cutaneous T cell lymphoma.

Journal: Haematologica

Published: October 30, 2025

Systemic complement protein levels as biomarkers of chemoradiotherapy response in anal squamous cell carcinoma.

Systemic complement protein levels as biomarkers of chemoradiotherapy response in anal squamous cell carcinoma.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: August 22, 2025

Investigating the Immune Effects of Radiotherapy in Non-Small Cell Lung Cancer-Results of the PD-RAD Study.

Investigating the Immune Effects of Radiotherapy in Non-Small Cell Lung Cancer-Results of the PD-RAD Study.

Journal: Oncology research

Published: August 18, 2025

Longitudinal plasma nano-proteomics reveals acute systemic responses to radiotherapy and predictive biomarkers of late toxicity.

Longitudinal plasma nano-proteomics reveals acute systemic responses to radiotherapy and predictive biomarkers of late toxicity.

Journal: Communications medicine

Published: August 14, 2025

CCR2-driven monocyte recruitment is protective against radiotherapy-induced intestinal toxicity.

CCR2-driven monocyte recruitment is protective against radiotherapy-induced intestinal toxicity.

Journal: Mucosal immunology

Published: November 29, 2024

Stromal cell inhibition of anti-CD20 antibody mediated killing of B-cell malignancies.

Stromal cell inhibition of anti-CD20 antibody mediated killing of B-cell malignancies.

Journal: Frontiers in cell and developmental biology

Published: July 31, 2023

Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radiation therapy and anti-PD-1/PD-L1.

Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radiation therapy and anti-PD-1/PD-L1.

Journal: Oncoimmunology

Published: June 19, 2023

Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer.

Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 06, 2022

Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations.

Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations.

Journal: Radiation oncology (London, England)

Published: July 28, 2020

Understanding the Effects of Radiotherapy on the Tumour Immune Microenvironment to Identify Potential Prognostic and Predictive Biomarkers of Radiotherapy Response.

Understanding the Effects of Radiotherapy on the Tumour Immune Microenvironment to Identify Potential Prognostic and Predictive Biomarkers of Radiotherapy Response.

Journal: Cancers

Published: July 17, 2020

Single-cell imaging of CAR T cell activity in vivo reveals extensive functional and anatomical heterogeneity.

Single-cell imaging of CAR T cell activity in vivo reveals extensive functional and anatomical heterogeneity.

Journal: The Journal of experimental medicine

Published: December 21, 2018

Showing 1-12 of 33

Last Updated: 09/26/2026